Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

Presentation TCT India 2025

Deep dive on Stent Failure / ISR: Cut – DEB strategy!

Presenter: Y. Vijayachandra Reddy

July 25, 2025

Presentation ISET 2019

Drug-Coated Therapy for ISR: Review of Options and Data

Presenter: Brian DeRubertis

January 30, 2019

Presentation CCVVC 2016

Advancements in the Treatment Options for ISRLaser, DCB, DES

Presenter: Craig M. Walker

June 15, 2016

Presentation TCT 2014

Sirolimus-Eluting Balloon Angioplasty Dilatation System for ISR Indication: The SABRE Trial

Presenter: Todd J. Brinton, Ian T. Meredith, Greg L. Kaluza, Stefan Verheye

September 16, 2014

Presentation TCT 2014

Sirolimus Nanocrystal Balloon-Based Delivery for Coronary DES-ISR

Presenter: Todd J. Brinton, Ian T. Meredith, Greg L. Kaluza, Sameer I. Dani

September 16, 2014

Presentation TCT 2014

Treatment Options for BMS and DES ISR: What Works Best?

Presenter: Robert S. Schwartz, Ron Waksman, Jorge F. Saucedo, Fernando Alfonso

September 14, 2014

Presentation TCT 2014

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Yelin Zhao

September 13, 2014

Presentation TCT 2014

DCB in BMS vs DES ISR: Insights from the RIBS Trials

Presenter: Run-Lin Gao, Jochen Wöhrle, Bruno Scheller, Fernando Alfonso

September 13, 2014

Presentation TCT 2013

RIBS IV-ISR Trial: Background and Trial Design

Presenter: Fernando Alfonso

October 31, 2013

Presentation TCT 2013

PEPCAD-China ISR Trial: 9-Month Angiographic and 1-Year Clinical Results

Presenter: Junbo Ge

October 31, 2013

Presentation TCT 2013

Critical Review of Drug-Coated Balloon Data for the Coronary ISR Application

Presenter: Bruno Scheller

October 31, 2013

Presentation TCT 2013

Angiosculpt DCB-ISR Trial

Presenter: Alexandre Abizaid

October 31, 2013

Presentation TCT 2013

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

Presenter: Bo Xu

October 29, 2013

Presentation EuroPCR 2013

PEPCAD China ISR

Presenter: Run-Lin Gao

May 23, 2013

Presentation TCT 2013

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Presenter: Myung-Hyun Kim, Byeong-Keuk Kim

January 31, 2013

Presentation TCT 2013

Comparison Of Long-term Outcomes With Everolimus-Eluting- and Sirolimus-Eluting Stents In Small Coronary Artery Disease

Presenter: Hironori Kitabata, Joshua Loh, Gabriel Sardi, Salem Badr, Danny Dvir, Israel Barbash, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2012

From IMPACT-ISR to BELLO: Urea-Based PCB Coating (Invatec)

Presenter: Antonio Colombo

October 25, 2012

Presentation TCT 2012

Coronary ISR: An Accepted Clinical Indication in the DES World?

Presenter: Huay Cheem Tan

October 25, 2012

Presentation

Resultados Clínicos y Tratamiento tras Fracaso de SLF: Ausencia de Factores de Riesgo Tradicionales en la Reestenosis Intra Stent (ISR)

Presenter: G. Maluenda

February 15, 2012

Presentation

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

Presenter: G. Maluenda

February 15, 2012

Advertisement

Deep dive on Stent Failure / ISR: Cut – DEB strategy!

Drug-Coated Therapy for ISR: Review of Options and Data

Advancements in the Treatment Options for ISRLaser, DCB, DES

Sirolimus-Eluting Balloon Angioplasty Dilatation System for ISR Indication: The SABRE Trial

Sirolimus Nanocrystal Balloon-Based Delivery for Coronary DES-ISR

Treatment Options for BMS and DES ISR: What Works Best?

TCT 267: Lower Mortality of Paclitaxel-Coated Balloon Compared with Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis: Two-Year Follow-up of the PEPCAD China ISR Trial

DCB in BMS vs DES ISR: Insights from the RIBS Trials

RIBS IV-ISR Trial: Background and Trial Design

PEPCAD-China ISR Trial: 9-Month Angiographic and 1-Year Clinical Results

Critical Review of Drug-Coated Balloon Data for the Coronary ISR Application

Angiosculpt DCB-ISR Trial

TCT-56. PEPCAD China ISR: A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon versus Paclitaxel-Eluting Stent for the Treatment of DES In-Stent Restenosis ...

PEPCAD China ISR

Efficacy and Safety of Drug-Eluting Balloon Compared to Drug-Eluting Stent for The Treatment of In-Stent Restenosis (ISR)

Comparison Of Long-term Outcomes With Everolimus-Eluting- and Sirolimus-Eluting Stents In Small Coronary Artery Disease

From IMPACT-ISR to BELLO: Urea-Based PCB Coating (Invatec)

Coronary ISR: An Accepted Clinical Indication in the DES World?

Resultados Clínicos y Tratamiento tras Fracaso de SLF: Ausencia de Factores de Riesgo Tradicionales en la Reestenosis Intra Stent (ISR)

Clinical Outcomes and Treatment After DES Failure: The Absence of Traditional Risk Factors for In-Stent Restenosis (ISR)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content